Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Pharmacogenomics Journal|March 26, 2014
Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapyF Graziano, V Catalano, P Lorenzini, et al.
Gynecologic Oncology|July 1, 1995
MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activityG G Garzetti, A Ciavattini, G Lucarini, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 7, 2000
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancerC Massacesi, R Bascioni, R Cellerino, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patientsM Scartozzi, M De Nictolis, E Galizia, et al.
La Ricerca in Clinica E in Laboratorio|April 1, 1983
Human papillomavirus in cervical condylomata. An immunohistochemical studyG M Mariuzzi, C A Beltrami, C Di Loreto, et al.
Minerva Chirurgica|June 15, 1993
[Angiomatoid malignant fibrous histiocytoma. Clinico-pathologic and immunohistochemical study of a case]M De Nictolis, S Tommasoni, G Goteri, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1996
72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and Serological studyM De Nictolis, S Garbisa, G Lucarini, et al.
Pageof 5